Financial incentives for generic drugs: case study on a reimbursement program

Area of Science:

• Health Economics
• Pharmaceutical Policy
• Pharmacoeconomics

Background:

• Financial incentives can influence patient medication choices.
• Reimbursement programs are utilized by companies to manage healthcare costs and improve access.

Purpose of the Study:

• To examine the impact of financial incentives on medication selection.
• To assess the economic outcomes of promoting generic medication use over reference drugs within a corporate reimbursement program.

Main Methods:

• A case study was conducted in a large supermarket involving 83,625 users from August 2005 to July 2007.
• Regression analysis and hypothesis testing were used to analyze medication consumption trends.
• Results were benchmarked against five other organizations and national data from Brazil.

Main Results:

• Financial incentives successfully boosted the consumption of generic drugs.
• The implementation of incentives did not lead to increased expenses for the company's reimbursement program.
• Generic medication uptake increased without compromising the overall cost-effectiveness of the program.

Conclusions:

• The study observed an increase in medication consumption, an unplanned but positive outcome.
• Corporate reimbursement programs utilizing financial incentives can positively impact medication access.
• Economic results indicate that incentivizing generic medication use is feasible and beneficial.